Pseudoxanthoma elasticum epidemiology and demographics
|
Pseudoxanthoma elasticum Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudoxanthoma elasticum epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pseudoxanthoma elasticum epidemiology and demographics |
|
FDA on Pseudoxanthoma elasticum epidemiology and demographics |
|
Pseudoxanthoma elasticum epidemiology and demographics in the news |
|
Blogs on Pseudoxanthoma elasticum epidemiology and demographics |
|
Risk calculators and risk factors for Pseudoxanthoma elasticum epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
Epidemiology and Demographics
PXE is a rare disease but the exact prevalence is unknown. The prevalence has been suggested to be approximately 1:50,000,[1] with an estimate of 150,000 affected in the world assuming the same global prevalence.[1] Females are twice as likely to be affected as males. The disease occurs in all ethnicities, but South Africans are more likely to have PXE as a result of a founder effect (i.e. it was relatively prevalent in the small group of people from whom most South Africans descend).[2]
References
- ↑ 1.0 1.1 Uitto, J. (2012). "Rare heritable skin diseases: targets for regenerative medicine". J Invest Dermatol. 132 (11): 2485–8. doi:10.1038/jid.2012.334. PMID 23069901. Unknown parameter
|month=ignored (help) - ↑ Allen, P.; Wightman, F. (1992). "Spectral pattern discrimination by children". J Speech Hear Res. 35 (1): 222–33. PMID 1735972. Unknown parameter
|month=ignored (help)